Bayesian Capital Management’s Synaptics SYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,046
Closed -$385K 948
2024
Q4
$385K Sell
5,046
-400
-7% -$30.3K 0.05% 430
2024
Q3
$423K Buy
+5,446
New +$437K 0.05% 411
2022
Q3
Sell
-3,240
Closed -$382K 1008
2022
Q2
$382K Sell
3,240
-5,376
-62% -$788K 0.07% 402
2022
Q1
$1.72M Buy
+8,616
New +$1.91M 0.26% 97
2021
Q3
Sell
-2,169
Closed -$337K 535
2021
Q2
$337K Sell
2,169
-1,834
-46% -$248K 0.09% 249
2021
Q1
$542K Buy
+4,003
New +$487K 0.12% 214
2020
Q3
Sell
-7,200
Closed -$433K 687
2020
Q2
$433K Sell
7,200
-8,644
-55% -$542K 0.1% 270
2020
Q1
$917K Buy
+15,844
New +$1.07M 0.2% 148
2018
Q2
Sell
-6,941
Closed -$317K 723
2018
Q1
$317K Sell
6,941
-13,700
-66% -$622K 0.08% 384
2017
Q4
$824K Buy
+20,641
New +$790K 0.17% 209
2017
Q3
Sell
-8,700
Closed -$450K 628
2017
Q2
$450K Buy
+8,700
New +$475K 0.17% 205

Other funds holding SYNA

Bayesian Capital Management's SYNA Position: Q1 2025 in Review

Bayesian Capital Management sold out of Synaptics (SYNA) in Q1 2025, closing a stake of 5,046 shares — an estimated $385K sold.

Bayesian Capital Management first reported a position in SYNA in Q2 2017 and held it in 11 quarters. The position peaked at $1.72M in Q1 2022. 265 funds tracked by Wall St. Rank hold SYNA as of Q1 2025.

  • Bayesian Capital Management reported no remaining Synaptics position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 5,046 Synaptics shares in Q1 2025, an estimated $385K.
  • Bayesian Capital Management first reported a position in Synaptics in Q2 2017 and held it in 11 quarters.
  • Bayesian Capital Management's Synaptics position peaked at $1.72M in Q1 2022.
  • 265 funds tracked by Wall St. Rank held Synaptics as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.